Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Materials Science & Engineering. C, Materials for Biological Applications|August 6, 2013
Enhanced apatite formation on Ti metal heated in PO2-controlled nitrogen atmosphereMasami Hashimoto, Kazumi Hayashi, Satoshi Kitaoka
Japanese Journal of Pharmacology|April 4, 2002
Antiproteinuric effect of KD3-671, an angiotensin II type 1 receptor antagonist, in rats with accelerated passive Heymann nephritisTadashi Nagamatsu, Toshiyuki Nagao, Kazumi Hayashi, et al.
International Immunopharmacology|November 4, 2017
Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cellsSadamu Homma, Kazumi Hayashi, Kosaku Yoshida, et al.
Thrombosis and Haemostasis|December 8, 2004
Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in miceYoshiyuki Iwatsuki, Tomihisa Kawasaki, Kazumi Hayashi, et al.
Plos One|December 1, 2017
Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cellsMasaki Ito, Kazumi Hayashi, Tamiko Minamisawa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 25, 2020
Therapeutic effects of interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 on diabetic nephropathy in type 2 diabetic miceMitsuhiro Kondo, Atsuo Tahara, Kazumi Hayashi, et al.
The Journal of Biological Chemistry|September 2, 2004
A novel Galphaq/11-selective inhibitorJun Takasaki, Tetsu Saito, Masatoshi Taniguchi, et al.
Pharmacological Research|February 20, 2003
Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reductionTakeyuki Yatsu, Masanao Sanagi, Akira Fujimori, et al.
Oncology Letters|September 15, 2018
Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinomaYasuhiro Arakawa, Yoshihiro Shirai, Kazumi Hayashi, et al.
Cancer Science|February 28, 2016
Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulationKazumi Hayashi, Eijiro Nagasaki, Shin Kan, et al.
Pageof 4